# hCG-activated PBMC-therapy in RIF Patients

> **NCT03267797** · NA · COMPLETED · sponsor: **SCARM Institute, Tabriz, Iran** · enrollment: 100 (actual)

## Conditions studied

- Recurrent Implantation Failure

## Interventions

- **OTHER:** Peripheral Blood Monouclear Cell
- **OTHER:** Phosphate Baffer Saline

## Key facts

- **NCT ID:** NCT03267797
- **Lead sponsor:** SCARM Institute, Tabriz, Iran
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-07
- **Primary completion:** 2018-09-25
- **Final completion:** 2019-07-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03267797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03267797, "hCG-activated PBMC-therapy in RIF Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03267797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*